Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 72 Paragraph 6: Difference between revisions
From GxPlex
Gxplex admin (talk | contribs) m 1 revision imported |
imported>GxPlexBot Import from GxPlex Excel |
||
| Line 5: | Line 5: | ||
Paragraph 6 | Paragraph 6 | ||
|RefLanguage=EN | |RefLanguage=EN | ||
| | |RefTags=TAG-00069-Imm-rhe ++ TAG-00211-Rec-ukt ++ TAG-00017-Spo-die ++ TAG-00202-Inv-Pro ++ TAG-00201-Cli-eSt | ||
| | |RefModule=5 | ||
| | |RefUnit=5.4.3 | ||
}} | }} | ||
| Line 15: | Line 15: | ||
|- | |- | ||
! colspan="2" class="gplx-infobox-header" | Reference Details | ! colspan="2" class="gplx-infobox-header" | Reference Details | ||
|- | |||
! Module | |||
| Module 5 — Unit 5.4.3 | |||
|- | |- | ||
! Scope | ! Scope | ||
| Line 32: | Line 35: | ||
| | | | ||
|- | |- | ||
! Tags | ! Tags | ||
| | | [[Glossary:TAG-00069-Imm-rhe|Urgent safety measure]], [[Glossary:TAG-00211-Rec-ukt|Product recall]], [[Glossary:TAG-00017-Spo-die|Sponsor]], [[Glossary:TAG-00202-Inv-Pro|Investigational device]], [[Glossary:TAG-00201-Cli-eSt|Clinical investigation]] | ||
|- | |||
| | |||
|- | |||
| | |||
|- | |- | ||
! Comment | ! Comment | ||
Revision as of 17:29, 15 July 2026
| Document information | |
|---|---|
| Reference | EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 |
| Validity area | EU |
| Scope(s) | MD |
| Document name | Regulation (EU) 2017/745 - Medical Device Regulation |
| Version / Revision | 20-Mar-2023 |
| Status | Current |
| Document type | Legal act |
| Language(s) | EN |
| Description | REGULATION (EU) 2017/745 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
| Reference Details | |
|---|---|
| Module | Module 5 — Unit 5.4.3 |
| Scope | MD |
| Document part | Article 72
Paragraph 6 |
| Language | EN |
| Original entry by | Florian Adragna |
| Contributors | |
| Tags | Urgent safety measure, Product recall, Sponsor, Investigational device, Clinical investigation |
| Comment | Sponsor obligation to establish emergency procedure for identification and recall of investigational devices |
Content
Conduct of a clinical investigation
6. The sponsor shall establish a procedure for emergency situations which enables the immediate identification and, where necessary, an immediate recall of the devices used in the investigation.
